GT Medical Technologies, announced that it has raised $37 million in Series D financing round. The financing round was led ...

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

Sionna Therapeutics SION) stock rises as the clinical-stage biopharma focused on cystic fibrosis therapies makes its public ...

Sionna late Thursday said it is selling nearly 10.6 million shares at $18 apiece in the IPO, compared with prior plans to offer about 8.82 million shares at between $16 and $18 each. The Waltham, Mass ...

Digital health firms in the city raised $4 billion in 2024, up 60% from the previous year, according to a report released ...

The gross proceeds from the initial public offering are expected to be approximately $191 million, before deducting underwriting discounts and commissions and other offering expenses, and excluding ...

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

Ategrity Specialty Insurance Co., a provider of excess and surplus insurance to small and midsize US companies, is exploring ...

Exo-Top was established under the jurisdiction of the State of Nevada. Basing Exo-Top in the U.S. offers key advantages, including proximity to strategic partners, access to a robust biopharma ...

Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, ...

Stay updated on the latest financial news and upcoming IPOs/SPACs with this article covering Titan America, Smithfield Foods, ...

Monday saw the release of JMP Securities' latest industry overview for the biotechnology sector, which highlighted key events from January 2025. The report noted a modest resurgence in the sector, ...